Renal Treatment Centers Southeast, Lp is a medicare approved dialysis facility center in Demopolis, Alabama and it has 10 dialysis stations. It is located in Marengo county at 505 Highway 80 W, Suite F, Demopolis, AL, 36732. You can reach out to the office of Renal Treatment Centers Southeast, Lp at (334) 287-1254. This dialysis clinic is managed and/or owned by Davita. Renal Treatment Centers Southeast, Lp has the following ownership type - Profit. It was first certified by medicare in November, 2014. The medicare id for this facility is 012679 and it accepts patients under medicare ESRD program.
| Name | Renal Treatment Centers Southeast, Lp |
|---|---|
| Location | 505 Highway 80 W, Suite F, Demopolis, Alabama |
| No. of Dialysis Stations | 10 |
| Medicare ID | 012679 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 505 Highway 80 W, Suite F, Demopolis, Alabama, 36732 | |
| (334) 287-1254 | |
News Archive
Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm p53 (DO-7) image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software.
Klas Tybrandt, principal investigator at the Laboratory of Organic Electronics at Linköping University, has developed new technology for long-term stable neural recording. It is based on a novel elastic material composite, which is biocompatible and retains high electrical conductivity even when stretched to double its original length.
COVID-19 has caused more than 2 million deaths worldwide since the World Health Organization declared it a pandemic in March 2020.
Imagine an electronic display nearly as clear as a window, or a curtain that illuminates a room, or a smartphone screen that doubles in size, stretching like rubber. Now imagine all of these being made from the same material.
› Verified 1 days ago
| NPI Number | 1285046979 |
| Organization Name | White Bluff Dialysis |
| Doing Business As | Renal Treatment Centers-southeast Lp |
| Address | 505 Us Highway 80 W Demopolis, Alabama, 36732 |
| Phone Number | (334) 287-1254 |
News Archive
Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm p53 (DO-7) image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software.
Klas Tybrandt, principal investigator at the Laboratory of Organic Electronics at Linköping University, has developed new technology for long-term stable neural recording. It is based on a novel elastic material composite, which is biocompatible and retains high electrical conductivity even when stretched to double its original length.
COVID-19 has caused more than 2 million deaths worldwide since the World Health Organization declared it a pandemic in March 2020.
Imagine an electronic display nearly as clear as a window, or a curtain that illuminates a room, or a smartphone screen that doubles in size, stretching like rubber. Now imagine all of these being made from the same material.
› Verified 1 days ago
| Dialysis patients with Hemoglobin data | 25 |
| Medicare patients who had average hemoglobin (hgb) greater than 12 g/dL | 4 |
News Archive
Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm p53 (DO-7) image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software.
Klas Tybrandt, principal investigator at the Laboratory of Organic Electronics at Linköping University, has developed new technology for long-term stable neural recording. It is based on a novel elastic material composite, which is biocompatible and retains high electrical conductivity even when stretched to double its original length.
COVID-19 has caused more than 2 million deaths worldwide since the World Health Organization declared it a pandemic in March 2020.
Imagine an electronic display nearly as clear as a window, or a curtain that illuminates a room, or a smartphone screen that doubles in size, stretching like rubber. Now imagine all of these being made from the same material.
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 44 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 377 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
News Archive
Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm p53 (DO-7) image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software.
Klas Tybrandt, principal investigator at the Laboratory of Organic Electronics at Linköping University, has developed new technology for long-term stable neural recording. It is based on a novel elastic material composite, which is biocompatible and retains high electrical conductivity even when stretched to double its original length.
COVID-19 has caused more than 2 million deaths worldwide since the World Health Organization declared it a pandemic in March 2020.
Imagine an electronic display nearly as clear as a window, or a curtain that illuminates a room, or a smartphone screen that doubles in size, stretching like rubber. Now imagine all of these being made from the same material.
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Renal Treatment Centers Southeast, Lp with elevated calcium levels.
| Patients with hypercalcemia | 44 |
| Hypercalcemia patient months | 377 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 47 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 27 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 30 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 21 |
| Patients with Serumphosphor greater than 7 mg/dL | 12 |
News Archive
Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm p53 (DO-7) image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software.
Klas Tybrandt, principal investigator at the Laboratory of Organic Electronics at Linköping University, has developed new technology for long-term stable neural recording. It is based on a novel elastic material composite, which is biocompatible and retains high electrical conductivity even when stretched to double its original length.
COVID-19 has caused more than 2 million deaths worldwide since the World Health Organization declared it a pandemic in March 2020.
Imagine an electronic display nearly as clear as a window, or a curtain that illuminates a room, or a smartphone screen that doubles in size, stretching like rubber. Now imagine all of these being made from the same material.
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 34 |
| Patient months included in arterial venous fistula and catheter summaries | 308 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 65 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 7 |
News Archive
Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm p53 (DO-7) image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software.
Klas Tybrandt, principal investigator at the Laboratory of Organic Electronics at Linköping University, has developed new technology for long-term stable neural recording. It is based on a novel elastic material composite, which is biocompatible and retains high electrical conductivity even when stretched to double its original length.
COVID-19 has caused more than 2 million deaths worldwide since the World Health Organization declared it a pandemic in March 2020.
Imagine an electronic display nearly as clear as a window, or a curtain that illuminates a room, or a smartphone screen that doubles in size, stretching like rubber. Now imagine all of these being made from the same material.
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 30 |
| Hospitalization Rate in facility | 102.5 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 259.9 |
| Hospitalization Rate: Lower Confidence Limit | 43.5 |
News Archive
Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm p53 (DO-7) image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software.
Klas Tybrandt, principal investigator at the Laboratory of Organic Electronics at Linköping University, has developed new technology for long-term stable neural recording. It is based on a novel elastic material composite, which is biocompatible and retains high electrical conductivity even when stretched to double its original length.
COVID-19 has caused more than 2 million deaths worldwide since the World Health Organization declared it a pandemic in March 2020.
Imagine an electronic display nearly as clear as a window, or a curtain that illuminates a room, or a smartphone screen that doubles in size, stretching like rubber. Now imagine all of these being made from the same material.
› Verified 1 days ago
The rate of readmission show you whether patients who were being treated regularly at Renal Treatment Centers Southeast, Lp were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate: Upper Confidence Limit | 16.2 |
News Archive
Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm p53 (DO-7) image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software.
Klas Tybrandt, principal investigator at the Laboratory of Organic Electronics at Linköping University, has developed new technology for long-term stable neural recording. It is based on a novel elastic material composite, which is biocompatible and retains high electrical conductivity even when stretched to double its original length.
COVID-19 has caused more than 2 million deaths worldwide since the World Health Organization declared it a pandemic in March 2020.
Imagine an electronic display nearly as clear as a window, or a curtain that illuminates a room, or a smartphone screen that doubles in size, stretching like rubber. Now imagine all of these being made from the same material.
› Verified 1 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Renal Treatment Centers Southeast, Lp get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| SIR: Upper Confidence Limit | 1.35 |
News Archive
Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm p53 (DO-7) image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software.
Klas Tybrandt, principal investigator at the Laboratory of Organic Electronics at Linköping University, has developed new technology for long-term stable neural recording. It is based on a novel elastic material composite, which is biocompatible and retains high electrical conductivity even when stretched to double its original length.
COVID-19 has caused more than 2 million deaths worldwide since the World Health Organization declared it a pandemic in March 2020.
Imagine an electronic display nearly as clear as a window, or a curtain that illuminates a room, or a smartphone screen that doubles in size, stretching like rubber. Now imagine all of these being made from the same material.
› Verified 1 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Renal Treatment Centers Southeast, Lp's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 27 |
| Transfusion Rate in facility | 38.8 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 147.4 |
| Transfusion Rate: Lower Confidence Limit | 12 |
News Archive
Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm p53 (DO-7) image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software.
Klas Tybrandt, principal investigator at the Laboratory of Organic Electronics at Linköping University, has developed new technology for long-term stable neural recording. It is based on a novel elastic material composite, which is biocompatible and retains high electrical conductivity even when stretched to double its original length.
COVID-19 has caused more than 2 million deaths worldwide since the World Health Organization declared it a pandemic in March 2020.
Imagine an electronic display nearly as clear as a window, or a curtain that illuminates a room, or a smartphone screen that doubles in size, stretching like rubber. Now imagine all of these being made from the same material.
› Verified 1 days ago
The rate of mortality show you whether patients who were being treated regularly at Renal Treatment Centers Southeast, Lp lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 67 |
| Mortality Rate in facility | 23.8 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 43.8 |
| Mortality Rate: Lower Confidence Limit | 11.4 |
News Archive
Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm p53 (DO-7) image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software.
Klas Tybrandt, principal investigator at the Laboratory of Organic Electronics at Linköping University, has developed new technology for long-term stable neural recording. It is based on a novel elastic material composite, which is biocompatible and retains high electrical conductivity even when stretched to double its original length.
COVID-19 has caused more than 2 million deaths worldwide since the World Health Organization declared it a pandemic in March 2020.
Imagine an electronic display nearly as clear as a window, or a curtain that illuminates a room, or a smartphone screen that doubles in size, stretching like rubber. Now imagine all of these being made from the same material.
› Verified 1 days ago
Renal Treatment Centers Southeast, Lp Location: 505 Highway 80 W, Suite F, Demopolis, Alabama, 36732 Phone: (334) 287-1254 |
News Archive
Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm p53 (DO-7) image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software.
Klas Tybrandt, principal investigator at the Laboratory of Organic Electronics at Linköping University, has developed new technology for long-term stable neural recording. It is based on a novel elastic material composite, which is biocompatible and retains high electrical conductivity even when stretched to double its original length.
COVID-19 has caused more than 2 million deaths worldwide since the World Health Organization declared it a pandemic in March 2020.
Imagine an electronic display nearly as clear as a window, or a curtain that illuminates a room, or a smartphone screen that doubles in size, stretching like rubber. Now imagine all of these being made from the same material.
› Verified 1 days ago